Market announcements

The Board of A2 Corporation is pleased to announce the appointment of Craig Louttit as the new Chief Financial Officer of the Company from early April 2014. This appointment follows the resignation of our present CFO Sarah Kolkman who has advised of her intention to return to Europe for family reasons. The Board thanks Sarah for her contribution since joining the Company and wishes her well for the future.

Craig joins the Group with a strong financial skill set and relevant international experience.
The appointment is consistent with the strategy to build management capability to support the ongoing growth of the company in international markets.

His previous roles have included:

• Senior finance roles with ASX listed “top 100” public company UGL Limited since 2007 including as General Manager Finance, Transport and Technology Systems, and Group Financial Controller including responsibility for management reporting, budgeting and forecasting processes, cash flow management, external reporting, and financial accounting;
• Senior finance roles with EMI Group PLC from 1999 in London, UK, including Head of Financial Reporting, Director Financial Analysis and Group Reporting Manager including responsibility for financial consolidation and implementation of IFRS;
• Various accounting roles with building materials manufacturer CSR, and international chartered accountancy firm, Deloitte Touche Tohmatsu.

Craig holds a Bachelor of Commerce from the University of NSW and is a Member of the Institute of Chartered Accountants in Australia.

For further information contact:

Geoffrey Babidge
Managing Director
A2 Corporation Limited
+61 2 96977008

A2C is a differentiated, premium-priced dairy company which is building a global business based on unique intellectual property relating to a2™ brand dairy products.

A2C has operations in Australia, New Zealand, the UK and China and is pursuing growth opportunities in Asia, North America & Europe.

A2C is listed on the NZX market and trades under the code ATM.